Home > > > > Report Detail

Global Furosemide Market Growth 2023-2029

Publisher Name :
Date: 01-Feb-2023
No. of pages: 93

Furosemide, sold under the brand name Lasix among others, is a medication used to treat fluid build-up due to heart failure, liver scarring, or kidney disease.

LPI (LP Information)' newest research report, the "Furosemide Industry Forecast" looks at past sales and reviews total world Furosemide sales in 2022, providing a comprehensive analysis by region and market sector of projected Furosemide sales for 2023 through 2029. With Furosemide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Furosemide industry.

This Insight Report provides a comprehensive analysis of the global Furosemide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Furosemide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Furosemide market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Furosemide and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Furosemide.

The global Furosemide market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Furosemide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Furosemide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Furosemide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Furosemide players cover Sanofi Aventis, US Pharm Holdings, Mylan, Sandoz, Hospira, West-Ward Pharms, Ivax Sub Teva Pharms, Emcure Pharms and Sun Pharm Inds, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Furosemide market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

- Injection

- Solution

- Tablet

Segmentation by application

- Hospital

- Pharmacy

- Clinics

- Others

This report also splits the market by region:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

- Sanofi Aventis

- US Pharm Holdings

- Mylan

- Sandoz

- Hospira

- West-Ward Pharms

- Ivax Sub Teva Pharms

- Emcure Pharms

- Sun Pharm Inds

Key Questions Addressed in this Report

What is the 10-year outlook for the global Furosemide market?

What factors are driving Furosemide market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Furosemide market opportunities vary by end market size?

How does Furosemide break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Global Furosemide Market Growth 2023-2029

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Furosemide Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Furosemide by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Furosemide by Country/Region, 2018, 2022 & 2029
2.2 Furosemide Segment by Type
2.2.1 Injection
2.2.2 Solution
2.2.3 Tablet
2.3 Furosemide Sales by Type
2.3.1 Global Furosemide Sales Market Share by Type (2018-2023)
2.3.2 Global Furosemide Revenue and Market Share by Type (2018-2023)
2.3.3 Global Furosemide Sale Price by Type (2018-2023)
2.4 Furosemide Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.4.3 Clinics
2.4.4 Others
2.5 Furosemide Sales by Application
2.5.1 Global Furosemide Sale Market Share by Application (2018-2023)
2.5.2 Global Furosemide Revenue and Market Share by Application (2018-2023)
2.5.3 Global Furosemide Sale Price by Application (2018-2023)
3 Global Furosemide by Company
3.1 Global Furosemide Breakdown Data by Company
3.1.1 Global Furosemide Annual Sales by Company (2018-2023)
3.1.2 Global Furosemide Sales Market Share by Company (2018-2023)
3.2 Global Furosemide Annual Revenue by Company (2018-2023)
3.2.1 Global Furosemide Revenue by Company (2018-2023)
3.2.2 Global Furosemide Revenue Market Share by Company (2018-2023)
3.3 Global Furosemide Sale Price by Company
3.4 Key Manufacturers Furosemide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Furosemide Product Location Distribution
3.4.2 Players Furosemide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Furosemide by Geographic Region
4.1 World Historic Furosemide Market Size by Geographic Region (2018-2023)
4.1.1 Global Furosemide Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Furosemide Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Furosemide Market Size by Country/Region (2018-2023)
4.2.1 Global Furosemide Annual Sales by Country/Region (2018-2023)
4.2.2 Global Furosemide Annual Revenue by Country/Region (2018-2023)
4.3 Americas Furosemide Sales Growth
4.4 APAC Furosemide Sales Growth
4.5 Europe Furosemide Sales Growth
4.6 Middle East & Africa Furosemide Sales Growth
5 Americas
5.1 Americas Furosemide Sales by Country
5.1.1 Americas Furosemide Sales by Country (2018-2023)
5.1.2 Americas Furosemide Revenue by Country (2018-2023)
5.2 Americas Furosemide Sales by Type
5.3 Americas Furosemide Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Furosemide Sales by Region
6.1.1 APAC Furosemide Sales by Region (2018-2023)
6.1.2 APAC Furosemide Revenue by Region (2018-2023)
6.2 APAC Furosemide Sales by Type
6.3 APAC Furosemide Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Furosemide by Country
7.1.1 Europe Furosemide Sales by Country (2018-2023)
7.1.2 Europe Furosemide Revenue by Country (2018-2023)
7.2 Europe Furosemide Sales by Type
7.3 Europe Furosemide Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Furosemide by Country
8.1.1 Middle East & Africa Furosemide Sales by Country (2018-2023)
8.1.2 Middle East & Africa Furosemide Revenue by Country (2018-2023)
8.2 Middle East & Africa Furosemide Sales by Type
8.3 Middle East & Africa Furosemide Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Furosemide
10.3 Manufacturing Process Analysis of Furosemide
10.4 Industry Chain Structure of Furosemide
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Furosemide Distributors
11.3 Furosemide Customer
12 World Forecast Review for Furosemide by Geographic Region
12.1 Global Furosemide Market Size Forecast by Region
12.1.1 Global Furosemide Forecast by Region (2024-2029)
12.1.2 Global Furosemide Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Furosemide Forecast by Type
12.7 Global Furosemide Forecast by Application
13 Key Players Analysis
13.1 Sanofi Aventis
13.1.1 Sanofi Aventis Company Information
13.1.2 Sanofi Aventis Furosemide Product Portfolios and Specifications
13.1.3 Sanofi Aventis Furosemide Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sanofi Aventis Main Business Overview
13.1.5 Sanofi Aventis Latest Developments
13.2 US Pharm Holdings
13.2.1 US Pharm Holdings Company Information
13.2.2 US Pharm Holdings Furosemide Product Portfolios and Specifications
13.2.3 US Pharm Holdings Furosemide Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 US Pharm Holdings Main Business Overview
13.2.5 US Pharm Holdings Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan Furosemide Product Portfolios and Specifications
13.3.3 Mylan Furosemide Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 Sandoz
13.4.1 Sandoz Company Information
13.4.2 Sandoz Furosemide Product Portfolios and Specifications
13.4.3 Sandoz Furosemide Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sandoz Main Business Overview
13.4.5 Sandoz Latest Developments
13.5 Hospira
13.5.1 Hospira Company Information
13.5.2 Hospira Furosemide Product Portfolios and Specifications
13.5.3 Hospira Furosemide Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Hospira Main Business Overview
13.5.5 Hospira Latest Developments
13.6 West-Ward Pharms
13.6.1 West-Ward Pharms Company Information
13.6.2 West-Ward Pharms Furosemide Product Portfolios and Specifications
13.6.3 West-Ward Pharms Furosemide Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 West-Ward Pharms Main Business Overview
13.6.5 West-Ward Pharms Latest Developments
13.7 Ivax Sub Teva Pharms
13.7.1 Ivax Sub Teva Pharms Company Information
13.7.2 Ivax Sub Teva Pharms Furosemide Product Portfolios and Specifications
13.7.3 Ivax Sub Teva Pharms Furosemide Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Ivax Sub Teva Pharms Main Business Overview
13.7.5 Ivax Sub Teva Pharms Latest Developments
13.8 Emcure Pharms
13.8.1 Emcure Pharms Company Information
13.8.2 Emcure Pharms Furosemide Product Portfolios and Specifications
13.8.3 Emcure Pharms Furosemide Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Emcure Pharms Main Business Overview
13.8.5 Emcure Pharms Latest Developments
13.9 Sun Pharm Inds
13.9.1 Sun Pharm Inds Company Information
13.9.2 Sun Pharm Inds Furosemide Product Portfolios and Specifications
13.9.3 Sun Pharm Inds Furosemide Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sun Pharm Inds Main Business Overview
13.9.5 Sun Pharm Inds Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Furosemide Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Furosemide Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Solution
Table 5. Major Players of Tablet
Table 6. Global Furosemide Sales by Type (2018-2023) & (MT)
Table 7. Global Furosemide Sales Market Share by Type (2018-2023)
Table 8. Global Furosemide Revenue by Type (2018-2023) & ($ million)
Table 9. Global Furosemide Revenue Market Share by Type (2018-2023)
Table 10. Global Furosemide Sale Price by Type (2018-2023) & (USD/Kg)
Table 11. Global Furosemide Sales by Application (2018-2023) & (MT)
Table 12. Global Furosemide Sales Market Share by Application (2018-2023)
Table 13. Global Furosemide Revenue by Application (2018-2023)
Table 14. Global Furosemide Revenue Market Share by Application (2018-2023)
Table 15. Global Furosemide Sale Price by Application (2018-2023) & (USD/Kg)
Table 16. Global Furosemide Sales by Company (2018-2023) & (MT)
Table 17. Global Furosemide Sales Market Share by Company (2018-2023)
Table 18. Global Furosemide Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Furosemide Revenue Market Share by Company (2018-2023)
Table 20. Global Furosemide Sale Price by Company (2018-2023) & (USD/Kg)
Table 21. Key Manufacturers Furosemide Producing Area Distribution and Sales Area
Table 22. Players Furosemide Products Offered
Table 23. Furosemide Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Furosemide Sales by Geographic Region (2018-2023) & (MT)
Table 27. Global Furosemide Sales Market Share Geographic Region (2018-2023)
Table 28. Global Furosemide Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Furosemide Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Furosemide Sales by Country/Region (2018-2023) & (MT)
Table 31. Global Furosemide Sales Market Share by Country/Region (2018-2023)
Table 32. Global Furosemide Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Furosemide Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Furosemide Sales by Country (2018-2023) & (MT)
Table 35. Americas Furosemide Sales Market Share by Country (2018-2023)
Table 36. Americas Furosemide Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Furosemide Revenue Market Share by Country (2018-2023)
Table 38. Americas Furosemide Sales by Type (2018-2023) & (MT)
Table 39. Americas Furosemide Sales by Application (2018-2023) & (MT)
Table 40. APAC Furosemide Sales by Region (2018-2023) & (MT)
Table 41. APAC Furosemide Sales Market Share by Region (2018-2023)
Table 42. APAC Furosemide Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Furosemide Revenue Market Share by Region (2018-2023)
Table 44. APAC Furosemide Sales by Type (2018-2023) & (MT)
Table 45. APAC Furosemide Sales by Application (2018-2023) & (MT)
Table 46. Europe Furosemide Sales by Country (2018-2023) & (MT)
Table 47. Europe Furosemide Sales Market Share by Country (2018-2023)
Table 48. Europe Furosemide Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Furosemide Revenue Market Share by Country (2018-2023)
Table 50. Europe Furosemide Sales by Type (2018-2023) & (MT)
Table 51. Europe Furosemide Sales by Application (2018-2023) & (MT)
Table 52. Middle East & Africa Furosemide Sales by Country (2018-2023) & (MT)
Table 53. Middle East & Africa Furosemide Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Furosemide Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Furosemide Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Furosemide Sales by Type (2018-2023) & (MT)
Table 57. Middle East & Africa Furosemide Sales by Application (2018-2023) & (MT)
Table 58. Key Market Drivers & Growth Opportunities of Furosemide
Table 59. Key Market Challenges & Risks of Furosemide
Table 60. Key Industry Trends of Furosemide
Table 61. Furosemide Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Furosemide Distributors List
Table 64. Furosemide Customer List
Table 65. Global Furosemide Sales Forecast by Region (2024-2029) & (MT)
Table 66. Global Furosemide Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Furosemide Sales Forecast by Country (2024-2029) & (MT)
Table 68. Americas Furosemide Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Furosemide Sales Forecast by Region (2024-2029) & (MT)
Table 70. APAC Furosemide Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Furosemide Sales Forecast by Country (2024-2029) & (MT)
Table 72. Europe Furosemide Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Furosemide Sales Forecast by Country (2024-2029) & (MT)
Table 74. Middle East & Africa Furosemide Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Furosemide Sales Forecast by Type (2024-2029) & (MT)
Table 76. Global Furosemide Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Furosemide Sales Forecast by Application (2024-2029) & (MT)
Table 78. Global Furosemide Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Sanofi Aventis Basic Information, Furosemide Manufacturing Base, Sales Area and Its Competitors
Table 80. Sanofi Aventis Furosemide Product Portfolios and Specifications
Table 81. Sanofi Aventis Furosemide Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 82. Sanofi Aventis Main Business
Table 83. Sanofi Aventis Latest Developments
Table 84. US Pharm Holdings Basic Information, Furosemide Manufacturing Base, Sales Area and Its Competitors
Table 85. US Pharm Holdings Furosemide Product Portfolios and Specifications
Table 86. US Pharm Holdings Furosemide Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 87. US Pharm Holdings Main Business
Table 88. US Pharm Holdings Latest Developments
Table 89. Mylan Basic Information, Furosemide Manufacturing Base, Sales Area and Its Competitors
Table 90. Mylan Furosemide Product Portfolios and Specifications
Table 91. Mylan Furosemide Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 92. Mylan Main Business
Table 93. Mylan Latest Developments
Table 94. Sandoz Basic Information, Furosemide Manufacturing Base, Sales Area and Its Competitors
Table 95. Sandoz Furosemide Product Portfolios and Specifications
Table 96. Sandoz Furosemide Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 97. Sandoz Main Business
Table 98. Sandoz Latest Developments
Table 99. Hospira Basic Information, Furosemide Manufacturing Base, Sales Area and Its Competitors
Table 100. Hospira Furosemide Product Portfolios and Specifications
Table 101. Hospira Furosemide Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 102. Hospira Main Business
Table 103. Hospira Latest Developments
Table 104. West-Ward Pharms Basic Information, Furosemide Manufacturing Base, Sales Area and Its Competitors
Table 105. West-Ward Pharms Furosemide Product Portfolios and Specifications
Table 106. West-Ward Pharms Furosemide Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 107. West-Ward Pharms Main Business
Table 108. West-Ward Pharms Latest Developments
Table 109. Ivax Sub Teva Pharms Basic Information, Furosemide Manufacturing Base, Sales Area and Its Competitors
Table 110. Ivax Sub Teva Pharms Furosemide Product Portfolios and Specifications
Table 111. Ivax Sub Teva Pharms Furosemide Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 112. Ivax Sub Teva Pharms Main Business
Table 113. Ivax Sub Teva Pharms Latest Developments
Table 114. Emcure Pharms Basic Information, Furosemide Manufacturing Base, Sales Area and Its Competitors
Table 115. Emcure Pharms Furosemide Product Portfolios and Specifications
Table 116. Emcure Pharms Furosemide Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 117. Emcure Pharms Main Business
Table 118. Emcure Pharms Latest Developments
Table 119. Sun Pharm Inds Basic Information, Furosemide Manufacturing Base, Sales Area and Its Competitors
Table 120. Sun Pharm Inds Furosemide Product Portfolios and Specifications
Table 121. Sun Pharm Inds Furosemide Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 122. Sun Pharm Inds Main Business
Table 123. Sun Pharm Inds Latest Developments
List of Figures
Figure 1. Picture of Furosemide
Figure 2. Furosemide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Furosemide Sales Growth Rate 2018-2029 (MT)
Figure 7. Global Furosemide Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Furosemide Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Injection
Figure 10. Product Picture of Solution
Figure 11. Product Picture of Tablet
Figure 12. Global Furosemide Sales Market Share by Type in 2022
Figure 13. Global Furosemide Revenue Market Share by Type (2018-2023)
Figure 14. Furosemide Consumed in Hospital
Figure 15. Global Furosemide Market: Hospital (2018-2023) & (MT)
Figure 16. Furosemide Consumed in Pharmacy
Figure 17. Global Furosemide Market: Pharmacy (2018-2023) & (MT)
Figure 18. Furosemide Consumed in Clinics
Figure 19. Global Furosemide Market: Clinics (2018-2023) & (MT)
Figure 20. Furosemide Consumed in Others
Figure 21. Global Furosemide Market: Others (2018-2023) & (MT)
Figure 22. Global Furosemide Sales Market Share by Application (2022)
Figure 23. Global Furosemide Revenue Market Share by Application in 2022
Figure 24. Furosemide Sales Market by Company in 2022 (MT)
Figure 25. Global Furosemide Sales Market Share by Company in 2022
Figure 26. Furosemide Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Furosemide Revenue Market Share by Company in 2022
Figure 28. Global Furosemide Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Furosemide Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Furosemide Sales 2018-2023 (MT)
Figure 31. Americas Furosemide Revenue 2018-2023 ($ Millions)
Figure 32. APAC Furosemide Sales 2018-2023 (MT)
Figure 33. APAC Furosemide Revenue 2018-2023 ($ Millions)
Figure 34. Europe Furosemide Sales 2018-2023 (MT)
Figure 35. Europe Furosemide Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Furosemide Sales 2018-2023 (MT)
Figure 37. Middle East & Africa Furosemide Revenue 2018-2023 ($ Millions)
Figure 38. Americas Furosemide Sales Market Share by Country in 2022
Figure 39. Americas Furosemide Revenue Market Share by Country in 2022
Figure 40. Americas Furosemide Sales Market Share by Type (2018-2023)
Figure 41. Americas Furosemide Sales Market Share by Application (2018-2023)
Figure 42. United States Furosemide Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Furosemide Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Furosemide Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Furosemide Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Furosemide Sales Market Share by Region in 2022
Figure 47. APAC Furosemide Revenue Market Share by Regions in 2022
Figure 48. APAC Furosemide Sales Market Share by Type (2018-2023)
Figure 49. APAC Furosemide Sales Market Share by Application (2018-2023)
Figure 50. China Furosemide Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Furosemide Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Furosemide Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Furosemide Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Furosemide Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Furosemide Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Furosemide Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Furosemide Sales Market Share by Country in 2022
Figure 58. Europe Furosemide Revenue Market Share by Country in 2022
Figure 59. Europe Furosemide Sales Market Share by Type (2018-2023)
Figure 60. Europe Furosemide Sales Market Share by Application (2018-2023)
Figure 61. Germany Furosemide Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Furosemide Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Furosemide Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Furosemide Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Furosemide Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Furosemide Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Furosemide Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Furosemide Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Furosemide Sales Market Share by Application (2018-2023)
Figure 70. Egypt Furosemide Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Furosemide Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Furosemide Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Furosemide Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Furosemide Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Furosemide in 2022
Figure 76. Manufacturing Process Analysis of Furosemide
Figure 77. Industry Chain Structure of Furosemide
Figure 78. Channels of Distribution
Figure 79. Global Furosemide Sales Market Forecast by Region (2024-2029)
Figure 80. Global Furosemide Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Furosemide Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Furosemide Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Furosemide Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Furosemide Revenue Market Share Forecast by Application (2024-2029)
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs